Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study
- DOI
- 10.1016/j.leukres.2026.108361
- Published
- 2026-12
- Container
- Leukemia Research
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2026.108361,
title = {Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study},
author = {Alisa Veenstra and Berdien E. Oortgiesen and Frank G.A. Jansman and Michel van Gelder and Mark-David Levin and Nic J.G.M. Veeger and Mels Hoogendoorn},
year = {2026},
journal = {Leukemia Research},
doi = {10.1016/j.leukres.2026.108361},
url = {https://doi.org/10.1016/j.leukres.2026.108361}
}RIS
TY - JOUR TI - Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study AU - Alisa Veenstra AU - Berdien E. Oortgiesen AU - Frank G.A. Jansman AU - Michel van Gelder AU - Mark-David Levin AU - Nic J.G.M. Veeger AU - Mels Hoogendoorn PY - 2026 JO - Leukemia Research DO - 10.1016/j.leukres.2026.108361 UR - https://doi.org/10.1016/j.leukres.2026.108361 ER -
APA
Veenstra, A., Oortgiesen, B. E., Jansman, F. G., Gelder, M. V., Levin, M., Veeger, N. J., & Hoogendoorn, M. (2026). Real-world outcomes after second-line therapy in chronic lymphocytic leukemia: A population-based study. Leukemia Research. https://doi.org/10.1016/j.leukres.2026.108361
Source records
- crossref · retrieved 2026-11-09T20:34:09.362Z